HomeTipranavirTipranavir + Ledipasvir And Sofosbuvir

Does Tipranavir Interact with Ledipasvir And Sofosbuvir?

Tipranavir and Ledipasvir And Sofosbuvir have a unknown drug interaction according to U.S. FDA drug labeling data. tipranavir/ritonavir ↓ ledipasvir ↓ sofosbuvir Coadministration of HARVONI with tipranavir/ritonavir is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Unknown
Tipranavir Class
Protease Inhibitor
Ledipasvir And Sofosbuvir Class
Hepatitis C Virus NS5A Inhibitor
Management
Consult your pharmacist
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Tipranavir and your doctor is considering prescribing Ledipasvir And Sofosbuvir (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Tipranavir+💊 Ledipasvir And Sofosbuvir(Ledipasvir And Sofosbuvir)

Severity & Interaction Details

ℹ️
unknown
Interaction documented — severity unclassified
The FDA label notes an interaction but the severity is not classified in our dataset.
Severity scale
MinorContra
On record
Yes
Drug A class
Protease Inhibitor
Drug B class
Hepatitis C Virus NS5A Inhibitor
Source
FDA drug label - ledipasvir and sofosbuvir

What this means in plain English

tipranavir/ritonavir ↓ ledipasvir ↓ sofosbuvir Coadministration of HARVONI with tipranavir/ritonavir is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of HARVONI.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Tipranavir and Ledipasvir And Sofosbuvir against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.